Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Do triglyceride-lowering drugs decrease risk of cardiovascular disease?

Current opinion in lipidology - 1 Aug 2017

Maki Kevin C, Dicklin Mary R

Abstract excerpt

PURPOSE OF REVIEW: This review summarizes the evidence supporting a relationship between lowering triglycerides (TGs) and TG-rich lipoprotein cholesterol (TGRL-C) levels and reduced atherosclerotic cardiovascular disease (ASCVD) event risk. RECENT FINDINGS: Data from observational investigations, including studies of genetic variants, provide evidence consistent with a causal relationship between elevations in TG...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Diseases
Share to Genetic Variation
Share to Hypolipidemic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Triglycerides

Source

Identifiers

PMID: 28441155
DOI: 10.1097/MOL.0000000000000424

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Do triglyceride-lowering drugs decrease risk of cardiovascular disease?PMID 28441155Read ↗

Triglycerides and ASCVD Risk Reduction: Recent Insights and Future Directions.Semantic proximity Read ↗

Genetics of Triglyceride-Rich Lipoproteins Guide Identification of Pharmacotherapy for Cardiovascular Risk Reduction.Semantic proximity Read ↗

Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology.Semantic proximity Read ↗

Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease.Semantic proximity Read ↗

A risk factor for atherosclerosis: triglyceride-rich lipoproteins.Semantic proximity Read ↗

Novel and future lipid-modulating therapies for the prevention of cardiovascular diseaseSemantic proximity Read ↗

Addressing dyslipidemic risk beyond LDL-cholesterol.Semantic proximity Read ↗

Serum Triglycerides and Atherosclerotic Cardiovascular Disease: Insights from Clinical and Genetic StudiesSemantic proximity Read ↗

HDL cholesterol concentrations and risk of atherosclerotic cardiovascular disease - Insights from randomized clinical trials and human genetics.Semantic proximity Read ↗

Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk.Semantic proximity Read ↗

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.Semantic proximity Read ↗

Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.